Lucy C. Crossman

672 total citations
6 papers, 317 citations indexed

About

Lucy C. Crossman is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Lucy C. Crossman has authored 6 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Hematology and 3 papers in Rheumatology. Recurrent topics in Lucy C. Crossman's work include Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Eosinophilic Disorders and Syndromes (3 papers). Lucy C. Crossman is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Eosinophilic Disorders and Syndromes (3 papers). Lucy C. Crossman collaborates with scholars based in United States, United Kingdom and Germany. Lucy C. Crossman's co-authors include Brian Druker, Michael W. Deininger, Thoralf Lange, Dietger Niederwieser, Stephanie G. Willis, Eric P. Stoffregen, Shannon K. McWeeney, Shadmehr Demehri, Byung Park and Stephen J. O’Brien and has published in prestigious journals such as Blood, Leukemia and Leukemia Research.

In The Last Decade

Lucy C. Crossman

6 papers receiving 308 citations

Peers

Lucy C. Crossman
Uwe Schwindel Germany
Bronte A. Jamison Australia
Alexandra L. Yeoman Australia
Haley Altamura Australia
Nataliia Glushko Ukraine
F. Giles United States
Fabian Lang Germany
Jana Linhartová Czechia
Lauren T. Adrian United States
Katy Knight United Kingdom
Uwe Schwindel Germany
Lucy C. Crossman
Citations per year, relative to Lucy C. Crossman Lucy C. Crossman (= 1×) peers Uwe Schwindel

Countries citing papers authored by Lucy C. Crossman

Since Specialization
Citations

This map shows the geographic impact of Lucy C. Crossman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy C. Crossman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy C. Crossman more than expected).

Fields of papers citing papers by Lucy C. Crossman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy C. Crossman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy C. Crossman. The network helps show where Lucy C. Crossman may publish in the future.

Co-authorship network of co-authors of Lucy C. Crossman

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy C. Crossman. A scholar is included among the top collaborators of Lucy C. Crossman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy C. Crossman. Lucy C. Crossman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Crossman, Lucy C., Thomas O’Hare, Thoralf Lange, et al.. (2005). A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib. Leukemia. 19(11). 1859–1862. 15 indexed citations
2.
Crossman, Lucy C., Marc Loriaux, Kristina Vartanian, et al.. (2005). Gene Expression Profiling of CML CD34+ Cells Prior to Imatinib Therapy Reveals Differences between Patients with and without Subsequent Complete Cytogenetic Response.. Blood. 106(11). 1222–1222. 2 indexed citations
3.
Crossman, Lucy C., Motomi Mori, Thoralf Lange, et al.. (2005). In chronic myeloid leukemia white cells from cytogenetic responders and non-responders to imatinib have very similar gene expression signatures.. PubMed. 90(4). 459–64. 52 indexed citations
4.
Willis, Stephanie G., Thoralf Lange, Shadmehr Demehri, et al.. (2005). High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy. Blood. 106(6). 2128–2137. 235 indexed citations
5.
Crossman, Lucy C., Michael C. Heinrich, Richard D. Press, et al.. (2004). Various Mechanisms Underlie Cytogenetic Refractoriness to Imatinib.. Blood. 104(11). 2091–2091. 2 indexed citations
6.
Crossman, Lucy C. & Stephen J. O’Brien. (2003). Clinical results with imatinib in chronic myeloid leukaemia. Leukemia Research. 28. 3–9. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uwe Schwindel Breakdown of academic impact, for papers by Bronte A. Jamison Breakdown of academic impact, for papers by Alexandra L. Yeoman Breakdown of academic impact, for papers by Haley Altamura Breakdown of academic impact, for papers by Nataliia Glushko Breakdown of academic impact, for papers by F. Giles Breakdown of academic impact, for papers by Fabian Lang Breakdown of academic impact, for papers by Jana Linhartová Breakdown of academic impact, for papers by Lauren T. Adrian Breakdown of academic impact, for papers by Katy Knight
Rankless by CCL
2026